These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3671416)

  • 1. Mitoxantrone salvage in heavily pretreated advanced breast cancer.
    Nathanson L; Williams ME
    Prog Clin Biol Res; 1987; 248():283-7. PubMed ID: 3671416
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined mitoxantrone therapy for heavily pretreated metastatic breast cancer].
    Yokoe T; Iino Y; Aoyagi H; Maemura M; Sugamata N; Takai Y; Horiguchi J; Ishida T; Morishita Y
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):169-71. PubMed ID: 8422183
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose escalation of mitoxantrone given with thiotepa and autologous bone marrow transplantation for metastatic breast cancer.
    Bowers C; Adkins D; Dunphy F; Harrison B; LeMaistre CF; Spitzer G
    Bone Marrow Transplant; 1993 Nov; 12(5):525-30. PubMed ID: 8298564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and histological study on breast cancer treated by preoperative mitoxantrone].
    Meng ZX
    Zhonghua Zhong Liu Za Zhi; 1990 Jul; 12(4):294-6. PubMed ID: 2272266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
    Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
    J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-line intra-arterial chemotherapy (IAC) with epirubicin and mitoxantrone in locally advanced breast cancer.
    Fiorentini G; Tsetis D; Bernardeschi P; Varveris C; Rossi S; Kalogeraki A; Athanasakis E; Dentico P; Kanellos P; Biancalani M; Almarashdah S; Zacharioudakis G; Saridaki Z; Chalkiadakis G; Xynos E; Zoras O
    Anticancer Res; 2003; 23(5b):4339-45. PubMed ID: 14666649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone in elderly women with advanced breast cancer: a phase II study.
    Repetto L; Simoni C; Venturino A; Biancardi V; Gasco M; Campora E; Rosso R
    Anticancer Res; 1995; 15(5B):2297-300. PubMed ID: 8572641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II evaluation of mitoxantrone in advanced non anaplastic thyroid cancer.
    Schlumberger M; Parmentier C
    Bull Cancer; 1989; 76(4):403-6. PubMed ID: 2752182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase II study of mitoxantrone in advanced breast cancer].
    Ogawa M; Kubo K; Tominaga T; Nomura Y; Ota K; Yoshida M; Taguchi T; Hoshino A
    Gan To Kagaku Ryoho; 1986 May; 13(5):1980-4. PubMed ID: 3707156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone as first-line chemotherapy for advanced breast cancer: results of a European collaborative study.
    Smyth JF; Cornbleet MA; Stuart-Harris RC; Smith IE; Coleman RE; Rubens RD; McDonald M; Mouridsen HT; Rainer H; van Oosterom AT
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):15-8. PubMed ID: 6484578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study.
    Levin M; Pandya KJ; Khandekar JD; Horton J; Glick JH; Bennett JM; Muggia FM; Falkson G
    Cancer Treat Rep; 1984 Dec; 68(12):1511-2. PubMed ID: 6509455
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitoxantrone and cyclophosphamide in advanced breast cancer: a pilot study.
    McDonald DB; Abu-Zahra H; Yoshida S; Binder H
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):19-22. PubMed ID: 6385260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of advanced and relapsing breast cancer with a combination of paclitaxel and mitoxantrone. South-Central Hellenic Oncology Group.
    Panagos GE
    Semin Oncol; 1997 Feb; 24(1 Suppl 3):S17-21. PubMed ID: 9071335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report].
    Izumi M; Iino Y; Yokoe T; Inoue T; Yamada T; Kobayashi I; Andoh T; Yokota T; Iijima T; Morishita Y
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):265-8. PubMed ID: 8311500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
    Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
    Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone in elderly patients with advanced breast cancer: pharmacokinetics, marrow and peripheral hematopoietic progenitor cells.
    Repetto L; Vannozzi MO; Balleari E; Venturino A; Granetto C; Bason C; Simoni C; Prencipe E; Queirolo P; Esposito M; Ghio R; Rosso R
    Anticancer Res; 1999; 19(1B):879-84. PubMed ID: 10216510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mitoxantrone in a combination regimen in advanced breast cancer].
    Hausmaninger H
    Wien Med Wochenschr; 1985 Dec; 135(23-24):594-7. PubMed ID: 4096006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study.
    Zander AR; Krüger W; Kröger N; Damon L; Königmann M; Berdel WE; Gieseking F; Schäfer-Eckart K; Möbus V; Frickhofen N; Wandt H; Illiger HJ; Metzner B; Kolbe K; Wörmann B; Trümper L; Huber C; Hossfeld DK; Maass H; Jonat W
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S24-5. PubMed ID: 8899165
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
    Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
    J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate, mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer patients.
    Merlini L; Secondo V; Mammoliti S; Bellotti P; Castello C; Gallo L
    Anticancer Res; 1994; 14(3B):1423-6. PubMed ID: 8067717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.